yourEra
Metabolic-Fit 76/100 · Grade C
A low-entry, all-in compounded program with both molecules, one price at every dose and a clean cancel-anytime policy — appealing, though the 'from' price isn't explained and the outcome claims are unverified marketing.
- $38.96 less per month on average than Trava Health
- scores 76/100 against Trava Health's 44
Pepti
Metabolic-Fit 58/100 · Grade C
Pepti publishes semaglutide prices of $99–$199 a month and tirzepatide prices of $159–$319, depending on dose. Medication, physician care and shipping are included without a separate membership fee.
- $18.96 less per month on average than Trava Health
- has an oral option if you would rather not inject
- scores 58/100 against Trava Health's 44
Strut Health
Metabolic-Fit 80/100 · Grade B−
Physician-founded and genuinely cheap, with both molecules in a lozenge or a shot and a free MD visit — but a February 2026 FDA misbranding letter is a caveat a mother should read before signing up.
- has an oral option if you would rather not inject
- scores 80/100 against Trava Health's 44
altRx
Metabolic-Fit 56/100 · Grade C
One of the lowest listed prices for compounded GLP-1s — $89 a month for semaglutide and $149 for tirzepatide, the same at every dose, with the visit, supplies and shipping included — from a company that received an FDA warning letter in June 2026 and treats every payment as final. Cancellation needs 72 hours' notice, and a documented trinitymeds trademark connection deserves attention.
- $28.96 less per month on average than Trava Health
- offers FDA-approved brand pens, not just compounded
- scores 56/100 against Trava Health's 44
ShedRx
Metabolic-Fit 76/100 · Grade C
The widest menu on our list — injections, sublingual lozenges, daily drops, four brand-name pens and the approved oral GLP-1 — with three compounding pharmacies named, prices published for every plan length, and cancellation terms among the most restrictive we have read.
- offers FDA-approved brand pens, not just compounded
- has an oral option if you would rather not inject
- scores 76/100 against Trava Health's 44
Harbor
Metabolic-Fit 63/100 · Grade C
Advertised dose-flat monthly plans are $99 for semaglutide and $149 for tirzepatide, with care, medication and shipping included. Confirm the selected supply and plan. Cancellation stops future renewal; after prescribing, payments including unused prepaid months are nonrefundable under the stated policy.
- $18.96 less per month on average than Trava Health
- scores 63/100 against Trava Health's 44
Lttl
Metabolic-Fit 56/100 · Grade C
Compounded semaglutide at $99 a month and tirzepatide at $149, month to month and the same price at every dose, plus a separate microdose line for anyone who wants a gentler metabolic effect rather than maximum weight loss. Lttl covers all 50 states and Washington D.C., says it prescribes and ships within 48 hours, and attributes compounding to U.S.A.-licensed pharmacies it does not name. The catalog runs well past weight loss into NAD+, sermorelin, glutathione and B12 from $79, so read the longevity menu as a separate business from the GLP-1 you came for. Prepaying for a year brings it to $89 and $139 a month, and the first-order discount of up to $140 is promotional.
- $18.96 less per month on average than Trava Health
- scores 56/100 against Trava Health's 44
SnagRx
Metabolic-Fit 56/100 · Grade C
Compounded semaglutide at $99 a month and tirzepatide at $149, month to month, one price at every dose that SnagRx says covers the medication, the supplies, the doctor review and shipping, with no membership fee and cancellation by email or phone. The $69 and $119 on its homepage are the 12-month prepay rates, billed once up front with no refund for unused months, and they sit under a live countdown clock with a lock-for-life promise that is marketing rather than a published term. It ships from licensed US pharmacies it never names, and publishes no list of the states it serves.
- $18.96 less per month on average than Trava Health
- scores 56/100 against Trava Health's 44
Midi Health
Metabolic-Fit 72/100 · Grade C
A menopause-focused program that bills insurance for eligible visits. The visit is covered in network or $250 self-pay, and the medication is billed separately from $164 per four-week supply — both figures published. It's built for perimenopause, not the postpartum year.
- offers FDA-approved brand pens, not just compounded
- scores 72/100 against Trava Health's 44